NSE:LALPATHLAB   DR LAL PATHLABS LTD
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where patients and healthcare providers are offered a broad range of diagnostic and related healthcare tests and services for use in: core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. The services of DLPL are aimed at individual patients, hospitals and other healthcare providers and corporates.

PROS

Company has reduced debt.
Company has been maintaining a healthy dividend payout of 35.7%



CONS

Stock is trading at 12.8 times its book value
Promoter holding has decreased over last quarter: -0.40%

免責事項

これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。